AMR101 (icosapent ethyl)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for AMR101 (icosapent ethyl), covering 2022-04-14 to 2022-04-14. Get the full timeline:
Most recent: Clinical Trial Update: A Study of AMR101 to Evaluate Its Ability to Reduce Cardiovascular Events in High-Risk Patients With Hypertriglyceridemia and on Statin [Phase 3]